source
- Relay drug shows early promise against rare blood vessel diseasesWhile early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments.BioPharma Dive · 3mo ago↗ source
- Nourish raises $100M for virtual nutrition careNourish, a telehealth platform that arranges virtual appointments with nutritionists, just raised a new round that bumped its valuation to $1.75 billion, according to a person familiar with the mat…Endpoints · 3mo ago↗ source
- STAT+: Eli Lilly tops prominent rankings on pharma R&D performanceA new set of lists ranks drug company laboratories on two criteria: innovation and invention.STAT · 3mo ago↗ source